Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Mereo Biopharma Group Plc ADR (MREO)

Mereo Biopharma Group Plc ADR (MREO)
2.00 x 1 2.64 x 6
Post-market by (Cboe BZX)
2.50 +0.17 (+7.30%) 04/22/25 [NASDAQ]
2.00 x 1 2.64 x 6
Post-market 2.48 -0.02 (-0.80%) 19:48 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
2.33
Day High
2.55
Open 2.36
Previous Close 2.33 2.33
Volume 2,355,900 2,355,900
Avg Vol 1,897,060 1,897,060
Stochastic %K 91.77% 91.77%
Weighted Alpha -47.12 -47.12
5-Day Change +0.60 (+31.58%) +0.60 (+31.58%)
52-Week Range 1.58 - 5.02 1.58 - 5.02
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 370,470
  • Shares Outstanding, K 159,000
  • Annual Sales, $ 0 K
  • Annual Income, $ -43,250 K
  • EBIT $ -47 M
  • EBITDA $ -47 M
  • 60-Month Beta 0.71
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.85

Options Overview Details

View History
  • Implied Volatility 396.65% ( +227.90%)
  • Historical Volatility 82.97%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 396.65% on 04/22/25
  • IV Low 5.30% on 05/15/24
  • Put/Call Vol Ratio 0.19
  • Today's Volume 891
  • Volume Avg (30-Day) 833
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 34,989
  • Open Int (30-Day) 32,358

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.01
  • Number of Estimates 3
  • High Estimate 0.07
  • Low Estimate -0.09
  • Prior Year -0.01
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.58 +58.23%
on 04/09/25
Period Open: 2.38
2.73 -8.42%
on 03/27/25
+0.12 (+5.04%)
since 03/21/25
3-Month
1.58 +58.23%
on 04/09/25
Period Open: 2.92
3.26 -23.20%
on 02/05/25
-0.42 (-14.38%)
since 01/22/25

Most Recent Stories

More News
Hidden Gems: 5 Stocks Under $10 With Massive Growth Potential

Uncover five promising stocks under $10, each poised for gains across diverse sectors for the second quarter of 2025.

SLI : 1.4600 (+4.29%)
F : 9.65 (+1.90%)
NOK : 5.28 (+4.14%)
MREO : 2.50 (+7.30%)
GT : 10.45 (+5.24%)
Mereo BioPharma CEO Dr. Denise Scots-Knight to Speak at Jefferies London Healthcare Conference on November 19, 2024

Mereo BioPharma will present at the Jefferies London Healthcare Conference on November 19, 2024. Live webcast available.Quiver AI SummaryMereo BioPharma Group plc announced that its CEO, Dr. Denise Scots-Knight,...

MREO : 2.50 (+7.30%)
Rubric Capital Management Comments on Mereo BioPharma Updated Operating Plan

Rubric Capital Management LP (“Rubric”), an investment advisor whose funds and accounts collectively own approximately 14% of the outstanding equity of Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo”...

MREO : 2.50 (+7.30%)
Rubric Capital Management Increases Slate of Proposed Mereo BioPharma Director Nominees to Five

Rubric Capital Management LP (“Rubric”), an investment advisor whose funds and accounts collectively own approximately 14% of the outstanding equity of Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo”...

MREO : 2.50 (+7.30%)
Rubric Capital Management Issues Open Letter to Mereo BioPharma Shareholders

Rubric Capital Management LP (“Rubric”), an investment advisor whose funds and accounts collectively own approximately 14% of the outstanding equity of Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo”...

MREO : 2.50 (+7.30%)
Mereo BioPharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

LONDON and MOUNTAIN VIEW, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO), (“Mereo” or “the Company”), a...

MREO : 2.50 (+7.30%)
Mereo BioPharma Announces the Presentation of Updated Data From a Phase 1b/2 Study of Etigilimab as a Poster at the 2022 American Society of Clinical Oncology Annual Meeting

Phase 1b/2 Study of Etigilimab and Nivolumab in Subjects with Select Locally Advanced or Metastatic Solid Tumors (ACTIVATE) 1 Complete Response (CR), 2...

MREO : 2.50 (+7.30%)
Mereo BioPharma Received Notification of Nasdaq Minimum Bid Price Deficiency

LONDON and REDWOOD CITY, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO), (“Mereo” or the “Company”), a clinical-stage...

MREO : 2.50 (+7.30%)
Mereo BioPharma to Host Conferene Call Highlighting Top-line Clinical Data from “ASTRAEUS” Phase 2 Study of Alvelestat

Call scheduled for Monday, May 9, 2022 at 10:30 a.m. ET...

MREO : 2.50 (+7.30%)
Mereo BioPharma to Host Conference Call Highlighting Top-line Clinical Data from “ASTRAEUS” Phase 2 Study of Alvelestat

Call scheduled for Monday, May 9, 2022 at 10:30 a.m. ET...

MREO : 2.50 (+7.30%)

Business Summary

Mereo BioPharma Group plc is a biopharmaceutical company focused on the development of therapeutics for rare diseases. The Company's rare disease product candidates, setrusumab for the treatment of osteogenesis imperfecta and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated...

See More

Key Turning Points

3rd Resistance Point 2.81
2nd Resistance Point 2.68
1st Resistance Point 2.59
Last Price 2.50
1st Support Level 2.37
2nd Support Level 2.24
3rd Support Level 2.15

See More

52-Week High 5.02
Fibonacci 61.8% 3.71
Fibonacci 50% 3.30
Fibonacci 38.2% 2.89
Last Price 2.50
52-Week Low 1.58

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro